Ras is a small GTPase that cycles between an inactive GDP-bound and an active GTP-bound form. A large variety of ligands that stimulate cell surface receptors induce the activation of Ras. Thus far, this activation could only be measured by the increase of GTP bound to Ras, which was precipitated from radio-labelled cell extract. We have used the minimal Ras-binding domain (RBD) of Raf1 (aa 51-131) to identify in vivo activated Ras. This novel method is based on the observation that RBD binds RasGTP in vitro with a Kd of 20 nM whereas the anity between RBD and RasGDP is three orders of magnitude lower. Here we show that the Gst-RBD fusion protein precipitates transfected RasL61 (RasGTP) but not RasN17 (RasGDP) from cell lysates.
Ras is a small GTPase that functions as a molecular switch in the transduction of signals generated by the activation of a variety of cell surface receptors. Activation of these receptors leads to the activation of a guanine nucleotide exchange factor, which induces the exchange of GDP for GTP. The active GTP-bound form of Ras, subsequently, interacts with one of its eectors responsible for the cellular responses of Ras activation. Ras is inactivated by hydrolysis of GTP, facilitated by GTPase activating proteins (GAPs) (Marshall, 1995; Pronk and Bos, 1994) . Ras became renowned after the ®nding that in a large number of human tumours, the Ras protein is constitutively in the active, GTP-bound form. This is due to a point mutation in one of the three Ras genes, which abolishes the intrinsic GTPase activity of the Ras protein (Bos, 1989) .
The analysis of the function of Ras was greatly facilitated by the development of an assay which could determine the ratio of GTP : GDP bound to Ras and thus the activation state of Ras (Downward et al., 1990; Gibbs et al., 1990; Satoh et al., 1990) . Using this assay many receptors have been identi®ed that can induce the activation of Ras upon ligand binding. These receptors include most, if not all, receptor tyrosine kinases, cytokine receptors and a large number of serpentine receptors (Pronk and Bos, 1994) . This method, however, is technically rather demanding and needs high doses of 32 P-orthophosphate to radiolabel GDP and GTP, which makes it unsuitable for routine analyses. Several proteins have been identi®ed which speci®cally interact with the GTP-bound form of Ras. These (putative) eectors of Ras include Raf1 (Koide et al., 1993; Moodie et al., 1993; Vojtek et al., 1993; Warne et al., 1993; Zhang et al., 1993) , phosphatidylinositol-3 kinase (RodriguezViciana et al., 1994) , the Ral guanine nucleotide exhange factors RalGDS (Spaargaren and Bischo, 1994) , Rgl (Kikuchi et al., 1994) and Rlf (Wolthuis et al., 1996) , the GTPase activating proteins p120RasGAP and neuro®bromin, Rin (Han and Colicelli, 1995) and several other Ras-binding proteins (Ponting and Benjamin, 1996) . Domains of these proteins responsible for Ras binding, may be suitable tools to identify speci®cally the GTP-bound form of Ras. In particular, the minimal Ras-binding domain (RBD) of Raf1 (aa 51-131) may serve as an activationspeci®c probe for Ras, since Herrmann et al. (1995) showed that RBD binds very tightly to the GTP-bound form of Ras (Kd 20 nM), whereas the anity for RasGDP is three orders of magnitude lower. Moreover, binding of this domain to RasGTP inhibits GAPinduced GTPase activity (Herrmann et al., 1995) .
We have investigated the validity of RBD as a tool to identify RasGTP. First we have con®rmed the speci®city for the GTP-bound form of Ras in a pull down experiment. We transfected into A14 cells oncogenic HRasL61, which is constitutively in the GTP-bound and dominant negative HrasN17, which is constitutively in the GDP-bound form. The cells were harvested after 36 h and Ras was identi®ed either by immunoblotting of total cell lysate or by precipitation with Gst-RBD. Whereas approximately equal amounts of either HRasL61 or HrasN17 are present in the transfected A14 cells (Figure 1 , right panel), only HrasL61 could be precipitated by Gst-RBD ( Figure 1 , left panel). This result indicates that indeed Gst-RBD can identify the GTP-bound form of Ras.
We next investigated whether Gst-RDB can serve as an activation-speci®c probe for endogenous Ras. We therefore used A14 cells of which we have shown previously that insulin can induce the activation of Ras (Burgering et al., 1991) . Figure 2a shows a comparison of the induction of RasGTP as determined by thè classic' labelling experiment and by in vitro binding to Gst-RBD. Two minutes after insulin stimulation the fraction of GTP-bound Ras was found to be increased from 15 to 35% (Figure 2a, left panel) and, similarly, a strong increase in the amount of Ras which binds to Gst-RBD was observed (Figure 2a, right panel) . Also, in a time course experiment, we observed the sustained activation of Ras after insulin stimulation as previously reported (Burgering et al., 1991) (Figure 2b ). From these results we conclude that Gst-RDB can be used to speci®cally identify in vitro activated Ras.
Finally, we employed the method to identify the activation of Ras by glial cell line-derived neurotrophic factor (GDNF). This ligand can activate the Retreceptor tyrosine kinase. We have previously shown for SK-P2 cells that activation of this receptor by GNDF cells results in the activation of ERK2 by a Rasmediated pathway. Yet, the activation of Ras was barely detectable, going from about 18 to 20% in the GTP-bound state (van Weering and , Figure  3 , left panel). However, if we perform a similar experiment using Gst-RBD as an activation-speci®c probe, we clearly see the increase in active Ras ( Figure  3, right panel) . From these results we conclude that RBD is also suitable to identify minor increases in RasGTP.
Together, we conclude that RBD is an excellent activation-speci®c probe for Ras, which allows the precipitation:
probe: Figure 1 Speci®c detection of RasGTP by Gst-RBD. A14 cells were transiently transfected with control plasmid, HRasL61 or HRasN17. Ras was identi®ed either by immunoblotting of total cell lysate (left panel) or by precipitation with Gst-RBD followed by immunoblotting (right panel). The monoclonal antibody Y13-259 was used to detect Ras. (HRasL61 has a slightly faster mobility than wt-Ras, which is visible in the right panel only, since this gel was electrophoresed longer than the gel in the left panel). Gst-RBD (aa51-131 of Raf1) fusion protein was constructed and isolated as previously described (Herrmann et al., 1995) . Brie¯y, pGEX 2T ± RBD was induced with IPTG and the bacteria were sonicated on ice 6 times for 1 min in PBS containing 0.5 mM DTT, 0.1 mM aprotinin, 1 mM leupeptin and 1 mM PMSF. Triton X-100 was added to a ®nal concentration of 1% and after gently stirring for 30 min at 48C up to 10% glycerol was added. The lysate was aliquotted and stored at 7808C for a limited period of time. The desired amount of crude Gst-RBD was thawed and incubated with glutathion-agarose beads at room temperature for 30 min. The beads were isolated by centrifugation and washed three times with RIPA buer. DNA transfected A14 cells were further grown in DME-medium containing 10% fetal calf serum for 40 h and cells from a 9 cm dish were lysed and scraped in 1 ml of RIPA buer containing 50 mM Tris pH 8.0, 150 mM NaCl, 0.5% DOC, 1% NP40, 0.1% SDS, 0.1 mM aprotinin, 1 mM leupeptin and 1 mM PMSF at 48C. Lysates were centrifuged at 14 000 r.p.m. for 8 min in an eppendorf centrifuge to remove nuclei. Gst-RBD, precoupled to glutathion-agarosebeads in RIPA buer, was added and the lysates were incubated at 48C for 30 min. Beads were collected by centrifugation, washed 3 times with RIPA buer and resuspended in sample buer (10% glycerol, 60 mM Tris, pH 6.8, 2% SDS, 300 mM b-mercaptoethanol). The protein samples were separated on a 15% SDSpolyacrylamide gel and subsequently transferred to a PVDF membrane by Western blotting. Ras was detected using the rat monoclonal antibody Y13-259 (16 h at 48C), followed by rabbitanti-rat antiserum (2 h at 48C) and HRP-coupled goat-anti-rabbit antiserum ( were grown in DF12 medium containing 10% fetal calf serum and serum-starved for 18 h. Subsequently, the cells were left untreated or were treated with GDNF (100 ng/ml) for 2 min. The left panel shows an in vivo labelling experiment where GTP/GDP bound to Ras was separated by thin layer chromatography (Burgering et al., 1991) . The right panel demonstrates the in vitro binding of Ras to Gst-RBD as described in legend Figure 1 detection of RasGTP by a simple, non-radioactive method. In addition, this method is rather sensitive, presumably due to the usually very low background of Ras binding to RBD in lysate from serum-starved cells (see Figure 2 and 3) . However, the method provides only semi-quantitative information on an increase of RasGTP, since no comparison can be made between the fractions of GTP-bound and GDP-bound Ras. One could circumvent this problem by measuring, in addition, the amount of Ras that is not bound to Gst-RDB (the GDP-bound fraction), but we found this procedure very unreliable. For most experiments, however, semi-quantitative measurements are sufficient. Furthermore, quantitative measurements for RasGTP are dicult anyway due to the intrinsic GTPase activity of Ras and the presence of GAPs in the cell lysate.
The success of the procedure is presumably based on the low nanomolar anity of RBD for RasGTP in vitro (Herrmann et al., 1995) . Indeed, we were unable to use the Ras binding domain of RalGDS as an activation-speci®c probe for Ras. This domain binds to Ras in vitro with a Kd of 1 mM (Herrmann et al., 1996) . However, this domain was found to be an excellent activation-speci®c probe for the small GTPase Rap1 (Franke et al., 1997) . This GTPase has an eector domain almost similar to the Ras eector domain. In the GTP-bound form Rap1 binds to the Ras/Rap binding domain of RalGDS with a Kd of 10 nM, whereas the anity for the GDP-bound form is undetectably low (Herrmann et al., 1996) . In contrast, RBD (of Raf1) does not recognise activated Rap1 or R-ras (another family member of the RasGTPases), presumably since the anities for the GTP-bound forms are too low (unpublished observations).
For Rap1 the use of an activation-speci®c probe was the only alternative to determine Rap1 activation, since no suitable antibodies were available to precipitate radio-labelled Rap1GTP/GDP to measure the ratio GTP : GDP. With this method we could show that Rap1 is activated rapidly and strongly in human platelets after thrombin stimulation (Franke et al., 1997) and in various other cell types after receptor stimulation (unpublished observations). Also, for other small GTPases activation-speci®c probes may be useful to study the mechanism of activation.
Activation-speci®c probes may have more general applications such as the identi®cation of activated GTPases in tissues which, in general, are very dicult to radio-label in vivo. Also tumour samples can be analysed for the presence of, for instance, RasGTP. It would be particularly interesting to search for tumours that have a high level of RasGTP but lack a point mutation in one of the Ras genes, which may be indicative for oncogenic activation of a protein that functions upstream from Ras.
